The Corporate Sales Representative (inside sales) is responsible for the development and management of a designated territory with the goal of maximizing sales while improving patient lives. Patients are central to all USL strategies, and the CSR will be responsible for developing business relationships with targeted neurologists, epileptologists, seizure specialists and other healthcare practitioners and members of the health care community. The CSR may work in a team with a Corporate Sales Specialist (CSS), Regional Trainer, Managed Care - Regional and National Account Manager to increase sales, market share and profitability of USL products. Time allocation of 75% inside sales and 25% field sales is expected; however, this may vary as business needs arise.
A Bachelor's degree required preferably in Business, Science, Communication or related field. Minimum of 2 + years of business to business or related healthcare experience required, with 6 to 12+ months of sales experience preferred. Experience selling and knowledge of CNS products and disorders, especially those associated in treating epilepsy is preferred. Valid Driver’s license required.
Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that has strived to deliver quality, affordable generic medications for nearly a century. In June 2017, Upsher-Smith was acquired by Sawai Pharmaceutical Co., Ltd., a large publicly traded generics company in Japan that had been seeking entry into the U.S. market. Upsher-Smith and Sawai share a strikingly similar family histor...y and hold many of the same cherished goals and values—most importantly, the philosophy of always putting patients first.
Upsher-Smith will continue to do those things we feel we do best—provide a consistent supply of quality, affordable medications, and invest in our historically strong industry relationships. And as we further organize into one global company with Sawai, we will begin to benefit from Sawai’s extensive resources and management focus. Ultimately, we believe our acquisition by Sawai represents a tremendous opportunity to leverage each other for growth worldwide as we embark together on an exciting new chapter in generics.